By Dr Bedoor Al Omran (Class of 2011), Neuroradiologist at Bahrain Defence Force Hospital - Royal Medical Services (RMS)

Neuroradiology plays an essential role in the diagnosis and management of neurological diseases. With the rapid development of imaging technologies, neuroradiology has become increasingly important in detecting neurological conditions early and guiding clinical decision-making. Today, imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are central to evaluating many neurological disorders, including stroke, brain tumours, multiple sclerosis and neurodegenerative diseases.

One of the most common conditions encountered in neuroradiology is stroke, which remains a leading cause of disability and mortality worldwide. Rapid imaging assessment is crucial in stroke management because treatment options depend heavily on distinguishing between ischemic and hemorrhagic stroke. Advanced techniques such as CT angiography and CT perfusion can identify vascular occlusions and assess cerebral blood flow, helping determine whether a patient may benefit from reperfusion therapies. Diffusion-weighted MRI is particularly sensitive in detecting acute ischemic changes and can identify brain injury within minutes of onset (Campbell & Khatri, 2020).

Another major group of diseases frequently evaluated in neuroradiology is brain tumours. MRI is considered the gold standard imaging modality for the assessment of intracranial tumours because of its excellent soft tissue contrast and multiplanar capabilities. Contrast-enhanced MRI allows better visualisation of tumour margins and associated oedema. Advanced MRI techniques such as perfusion imaging, diffusion tensor imaging (DTI) and MR spectroscopy provide additional information about tumour vascularity, cellularity and metabolic activity. These techniques can assist clinicians in differentiating tumour types, assessing tumour grade, and planning surgical or radiation therapy (Louis et al., 2021).

Multiple sclerosis (MS) is another neurological condition in which neuroradiology plays a crucial diagnostic role. MRI is highly sensitive in detecting demyelinating lesions in the brain and spinal cord. Typical MS lesions appear as hyperintense areas on T2-weighted and FLAIR sequences. Importantly, MRI can detect lesions prior to clinical symptoms, allowing earlier diagnosis and monitoring of disease progression or treatment response (Thompson et al., 2018).

In recent years, significant advances in imaging technology have improved the evaluation of neurological conditions. High-field MRI systems, such as 3-Tesla scanners, provide higher spatial resolution and improved signal-to-noise ratio, enabling better visualisation of subtle abnormalities. Functional MRI (fMRI) assesses brain activity by detecting changes in blood oxygenation, which is particularly useful for pre-surgical planning in patients with brain tumours or epilepsy. Similarly, PET imaging is increasingly used to evaluate neurodegenerative diseases, such as Alzheimer's disease, by detecting metabolic changes or abnormal protein deposition before structural brain changes become visible on conventional imaging (Johnson et al., 2019).

Another rapidly evolving area in neuroradiology is the use of artificial intelligence (Al) and advanced image analysis. Machine learning algorithms can assist radiologists in detecting abnormalities, segmenting tumours, and analysing large imaging datasets more efficiently. Al-based tools have shown promising results in stroke detection, intracranial haemorrhage identification, and brain tumour classification. These technologies can improve diagnostic accuracy, reduce reporting time, and support more personalised treatment strategies (Lundervold & Lundervold, 2019).

The integration of advanced imaging techniques and Al has already begun to influence clinical decision-making and patient outcomes. In acute stroke care, rapid imaging analysis can help identify patients who may benefit from mechanical thrombectomy even beyond traditional treatment time windows. In oncology, advanced imaging provides valuable information for treatment planning, monitoring therapeutic response, and detecting tumour recurrence.

Similarly, imaging biomarkers are increasingly used in research and clinical practice to detect early neurodegenerative changes.

Looking ahead, emerging technologies such as ultra-high-field MRI, hybrid PET/MRI systems, and more sophisticated Al-driven image analysis are expected to further transform neuroradiology. These innovations may enable more precise disease characterisation and earlier diagnosis. As the field continues to evolve, the next generation of neuroradiologists will need strong skills not only in imaging interpretation but also in data analysis, technological literacy, and interdisciplinary collaboration. These competencies will be essential for maximising the benefits of advanced imaging and improving patient care.

References

1. Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129-142.
2. Johnson KA, Becker JA, Rowe CC, Villemagne VL. Amyloid imaging in Alzheimer's disease: basic concepts and clinical applications. Journal of Nuclear Medicine. 2019;60(6):739-745.
3. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system. Acta Neuropathologica. 2021;142(4):733-745.
4. Lundervold AS, Lundervold A. An overview of deep learning in medical imaging focusing on MRI. Zeitschrift fur Medizinische Physik. 2019;29(2):102-127.
5. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology. 2018;17(2):162-173.